[HTML][HTML] Role of vascular endothelial growth factor B in nonalcoholic fatty liver disease and its potential value

YQ Li, L Xin, YC Zhao, SQ Li, YN Li - World Journal of Hepatology, 2023 - ncbi.nlm.nih.gov
Nonalcoholic fatty liver disease (NAFLD) refers to fatty liver disease caused by liver injury
factors other than alcohol. The disease is characterized by diffuse fat infiltration, including …

[HTML][HTML] Vascular endothelial growth factor B improves impaired glucose tolerance through insulin-mediated inhibition of glucagon secretion

YQ Li, LY Zhang, YC Zhao, F Xu, ZY Hu… - World Journal of …, 2023 - ncbi.nlm.nih.gov
BACKGROUND Impaired glucose tolerance (IGT) is a homeostatic state between
euglycemia and hyperglycemia and is considered an early high-risk state of diabetes. When …

[PDF][PDF] PI3K inhibitor promotes tumor vessel normalization and improves treatment outcomes of breast cancer with doxorubicin

B Li, Y Tian, J Huang, H Zhang, J Zhao… - European Journal of …, 2023 - oss.ejgo.net
HS-173 is a specific inhibitor of the Phosphoinositide 3-Kinase α (PI3Kα) subtype. Although
it was shown to potentially inhibit tumor angiogenesis, experimental validation studies are …

Differentiation of Cav1. 2 and Cav1. 3 pharmacology and role of RyR2 in pancreatic beta-cell electrophysiology

S Tang - 2021 - search.proquest.com
The L-type VGCC subtypes, including subtypes C av 1-1.4, have been shown to play critical
roles in various cellular activities, including muscle contraction, hormone secretion, and …